NMI and glioblastoma: Compared to 16 cases of normal tissues, the immunoreactivity of NMI was unequivocally elevated in human gliomas and increased according to WHO grades, while the highest expression of NMI was observed in GBM samples (Figure 1A and 1B, Table 1).